Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-30

Clinical Trial Update: Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III [Phase 3]

View source ↗

Summary

A Phase 3 trial of Tenecteplase for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenecteplase (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 3 | Status: COMPLETED